RSS Channels IndexFeature Channels
Blood Disorders
Filters:
MedicineChannels:Keywords: |
Discovery May Help Prevent Chemotherapy-Induced AnemiaAlbert Einstein College of Medicine researchers have discovered that chemo induces a type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation. The findings suggest that combining chemotherapy with nerve-protecting agents may prevent long-term bone marrow injury. |
Embargo expired: 5/5/2013 1:00 PM EDT
Released: 5/3/2013 5:00 PM EDT
Albert Einstein College of Medicine of Yeshiva University |
MedicineChannels:Keywords: |
UC Davis Research Advances Efforts to Precent Dangerous Blood ClotsStudy will help physicians calculate risk of post-surgical venous thromboembolisms. New research from the UC Davis Comprehensive Cancer Center may help clinicians determine which patients are at highest risk for post-surgical blood clots in the legs or lungs. |
Released: 3/20/2013 3:35 PM EDT
UC Davis Comprehensive Cancer Center |
ScienceChannels:Keywords: |
White Blood Cells Found to Play Key Role in Controlling Red Blood Cell LevelsResearchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages – white blood cells that play a key role in the immune response – also help to both produce and eliminate the body’s red blood cells (RBCs). The findings could lead to novel therapies for diseases or conditions in which the red blood cell production is thrown out of balance. The study, conducted in mice, is published today in the online edition of the journal Nature Medicine. |
Embargo expired: 3/17/2013 2:00 PM EDT
Released: 3/14/2013 10:00 AM EDT
Albert Einstein College of Medicine of Yeshiva University |
MedicineChannels:Keywords: |
New Treatment for Sickle Cell Brings Hope and a Cure to Chicago Area PatientsThanks to a third brother, two brothers were cured of sickle cell disease through a relatively uncommon type of stem cell transplant without chemotherapy. |
Released: 3/4/2013 5:45 PM EST
University of Illinois at Chicago |
MedicineChannels:Keywords: |
Could an Old Antidepressant Treat Sickle Cell Disease?
An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team has spent more than three decades studying the basic biology of the condition. |
Released: 2/18/2013 5:00 PM EST
University of Michigan Health System |
MedicineChannels:Keywords: |
New Study On Hepatitis C Drug Treatment in vivo and in vitro
Hepatitis C virus (HCV) infection affects 4 million in the US and is the prirmary cause of liver cirrhosis and liver cancer. New research shows that daclatasvir, an ant - HCV drug, has two modes of action and provides a more accurate estimate of the HCV half-life. |
Embargo expired: 2/18/2013 3:00 PM EST
Released: 2/15/2013 3:00 PM EST
Loyola University Health System |
ScienceChannels:Keywords: |
Designer Blood Clots Could Improve Soldier Survival
When it comes to healing the terrible wounds of war, success may hinge on the first blood clot – the one that begins forming on the battlefield right after an injury. Researchers believe the initial response to injury may control subsequent healing. |
Embargo expired: 2/15/2013 11:00 AM EST
Released: 2/11/2013 7:10 PM EST
Georgia Institute of Technology, Research Communications |
MedicineChannels:Keywords: |
Study Finds Use of Disinfection Cap Is Associated with Fewer Bloodstream InfectionsPatients at NorthShore University HealthSystem are now better protected against potentially deadly infections, according to a newly published study. |
Released: 1/3/2013 9:00 AM EST
NorthShore University HealthSystem |
MedicineChannels:Keywords: |
Lower Thresholds for Blood Transfusion Found to Have No Adverse Effects on Patients’ Health
Today, in a new section called JAMA Clinical Evidence Synopsis, the Journal of the American Medical Association (JAMA), published a summary of the systematic review of the 19 clinical trials that compare higher versus lower hemoglobin thresholds in red blood cell transfusion. The comprehensive review concludes that there is no significant difference in patient outcomes with red blood cell transfusions using lower threshold levels. |
Released: 1/2/2013 3:00 PM EST
Robert Wood Johnson Medical School |
MedicineChannels:Keywords: |
Surviving Sepsis with LECT2Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th. |
Embargo expired: 12/17/2012 12:00 PM EST
Released: 12/12/2012 3:00 PM EST
Rockefeller University Press |